Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5104942 | Value in Health | 2016 | 9 Pages |
Abstract
The British Columbia ChEI coverage policy was associated with significantly prolonged persistence with donepezil and galantamine, but not rivastigmine.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Anat MD, PhD, Greg BSc, Ken MD, PhD, Neena L. PhD, FRSC, FCAHS,